Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo

Virology Journal

Volumn 10, Issue , 2013, Pages

  Meyer, Christine ^a   Dewane, Jesse ^a   Haberthur, Kristen ^a   Engelmann, Flora ^b   Arnold, Nicole ^b   Gray, Wayne ^c   Messaoudi, Ilhem ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

Bacterial artificial chromosome; Herpesvirus; Pathogenesis; Rhesus macaque; Simian varicella virus

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; AUTOPSY; B LYMPHOCYTE; BACTERIAL ARTIFICIAL CHROMOSOME; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; GENETIC ANALYSIS; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION; KINETICS; LUNG LAVAGE; NONHUMAN; RASH; RHESUS MONKEY; SENSORY GANGLION; SIMIAN VARICELLA VIRUS; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CERCOPITHECINE HERPESVIRUS 9; HERPES ZOSTER; HERPESVIRIDAE; HUMAN HERPESVIRUS 3; MACACA MULATTA; SAL VIEJA VIRUS;

ANIMALS; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHICKENPOX; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE MODELS, ANIMAL; GANGLIA, SENSORY; MACACA MULATTA; VARICELLOVIRUS; VIRUS LATENCY;

EID: 84883508502     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-278     Document Type: Article

References (56)

1. Vaccination against herpes zoster and postherpetic neuralgia. Oxman MN, Levin MJ, J Infect Dis 2008 197 Suppl 2 228 S236 18419402
2. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Oxman MN, et al. N Engl J Med 2005 352 22 2271 2284 10.1056/NEJMoa051016 15930418 (Pubitemid 40740551)
3. A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus. Clarkson MJ, Thorpe E, McCarthy K, Arch Gesamte Virusforsch 1967 22 1 219 234 4301195
4. Simian varicella virus DNA in dorsal root ganglia. Mahalingam R, et al. Proc Natl Acad Sci USA 1991 88 7 2750 2752 10.1073/pnas.88.7.2750 1849275 (Pubitemid 21916496)
5. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. Messaoudi I, et al. PLoS Pathog 2009 5 11 1000657 10.1371/journal.ppat.1000657 19911054
6. DNA sequence and genetic organization of the unique short (US) region of the simian varicella virus genome. Fletcher TM 3rd, Gray WL, Virology 1993 193 2 762 773 10.1006/viro.1993.1185 8384754
7. The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Gray WL, et al. Virology 1992 186 2 562 572 10.1016/0042-6822(92)90022-H 1310185
8. The DNA sequence of the simian varicella virus genome. Gray WL, et al. Virology 2001 284 1 123 130 10.1006/viro.2001.0912 11352673 (Pubitemid 32476701)
9. Simian varicella virus DNA shares homology with human varicella-zoster virus DNA. Gray WL, Oakes JE, Virology 1984 136 1 241 246 10.1016/0042-6822(84) 90263-0 6330994 (Pubitemid 14089602)
10. The complete DNA sequence of varicella-zoster virus. Davison AJ, Scott JE, J Gen Virol 1986 67 Pt 9 1759 1816 3018124 (Pubitemid 16017266)
11. Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome. Gray WL, et al. Arch Virol 2011 156 5 739 746 10.1007/s00705-010-0889-4 21487663
12. Simian varicella virus gene 61 encodes a viral transactivator but is non-essential for in vitro replication. Gray WL, et al. Arch Virol 2007 152 3 553 563 10.1007/s00705-006-0866-0 17115302 (Pubitemid 46363594)
13. Age and immune status of rhesus macaques impact simian varicella virus gene expression in sensory ganglia. Meyer C, Dewane J, Kerns A, Haberthur K, Barron A, Park B, Messaoudi I, J Virol 2013 87 8294 8306 10.1128/JVI.01112-13 23698305
14. Monocyte chemoattractant protein-1 (MCP-1): an overview. Deshmane SL, et al. J Interferon Cytokine Res 2009 29 6 313 326 10.1089/jir.2008.0027 19441883
15. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Yamashita U, Kuroda E, Crit Rev Immunol 2002 22 2 105 114 12433129 (Pubitemid 35244753)
16. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Bernhagen J, et al. Nat Med 2007 13 5 587 596 10.1038/nm1567 17435771 (Pubitemid 46828480)
17. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. Liu MT, et al. J Immunol 2001 166 3 1790 1795 11160225 (Pubitemid 32114664)
18. Macrophage inflammatory protein-1. Maurer M, von Stebut E, Int J Biochem Cell Biol 2004 36 10 1882 1886 10.1016/j.biocel.2003.10.019 15203102 (Pubitemid 38760018)
19. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. Liu MT, et al. J Immunol 2000 165 5 2327 2330 10946253 (Pubitemid 30660672)
20. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Griffiths-Johnson DA, et al. Biochem Biophys Res Commun 1993 197 3 1167 1172 10.1006/bbrc.1993.2599 7506538 (Pubitemid 24042744)
21. Cellular responses to interferon-g. Boehm U, et al. Annu Rev Immunol 1997 15 749 795 10.1146/annurev.immunol.15.1.749 9143706 (Pubitemid 27169298)
22. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Esposito E, Cuzzocrea S, Curr Med Chem 2009 16 24 3152 3167 10.2174/092986709788803024 19689289
23. Biological and clinical aspects of interleukin 6. Hirano T, et al. Immunol Today 1990 11 12 443 449 2127356
24. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Liao W, Lin JX, Leonard WJ, Immunity 2013 38 1 13 25 10.1016/j.immuni.2013.01.004 23352221
25. Interleukin 15: biology and relevance to human disease. Fehniger TA, Caligiuri MA, Blood 2001 97 1 14 32 10.1182/blood.V97.1.14 11133738 (Pubitemid 32061238)
26. Interleukin-1 receptor antagonist: role in biology. Arend WP, et al. Annu Rev Immunol 1998 16 27 55 10.1146/annurev.immunol.16.1.27 9597123 (Pubitemid 28183358)
27. Interleukin-10. Moore KW, et al. Annu Rev Immunol 1993 11 165 190 10.1146/annurev.iy.11.040193.001121 8386517 (Pubitemid 23115005)
28. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Welte K, et al. Proc Natl Acad Sci USA 1985 82 5 1526 1530 10.1073/pnas.82.5.1526 3871951 (Pubitemid 15120576)
29. IL-12: initiation cytokine for cell-mediated immunity. Scott P, Science 1993 260 5107 496 497 10.1126/science.8097337 8097337 (Pubitemid 23161612)
30. Epidermal growth factor. Carpenter G, Cohen S, J Biol Chem 1990 265 14 7709 7712 2186024 (Pubitemid 20158927)
31. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. Yu PJ, et al. J Cell Biochem 2007 100 5 1100 1108 10.1002/jcb.21116 17131363 (Pubitemid 46480393)
32. Growth factors. A scattering of factors. Warn R, Curr Biol 1994 4 11 1043 1045 10.1016/S0960-9822(00)00239-6 7874492
33. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). Byrne AM, Bouchier-Hayes DJ, Harmey JH, J Cell Mol Med 2005 9 4 777 794 10.1111/j.1582-4934.2005.tb00379.x 16364190 (Pubitemid 43116546)
34. Development and homeostasis of T cell memory in rhesus macaque. Pitcher CJ, et al. J Immunol 2002 168 1 29 43 11751943 (Pubitemid 34014099)
35. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Nagaike K, et al. Vaccine 2004 22 29-30 4069 4074 15364458 (Pubitemid 39208772)
36. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. Tischer BK, et al. J Virol 2007 81 23 13200 13208 10.1128/JVI.01148-07 17913822 (Pubitemid 350156957)
37. Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Yoshii H, et al. Vaccine 2007 25 27 5006 5012 10.1016/j.vaccine.2007.04.064 17540483 (Pubitemid 46879998)
38. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. Zhang Z, et al. J Virol 2007 81 17 9024 9033 10.1128/JVI.02666-06 17581997 (Pubitemid 47311446)
39. The varicella-zoster virus genome. Cohen JI, Curr Top Microbiol Immunol 2010 342 1 14 10.1007/82-2010-10 20225013
40. Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. Zhang Z, et al. PLoS Pathog 2010 6 1000971 10.1371/journal.ppat.1000971 20617166
41. Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. Chaudhuri V, et al. J Virol 2008 82 20 10231 10246 10.1128/JVI.01890-07 18684828
42. ORF7 of varicella-zoster virus is a neurotropic factor. Selariu A, et al. J Virol 2012 86 16 8614 8624 10.1128/JVI.00128-12 22674980
43. Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. Oliver SL, et al. J Virol 2009 83 15 7495 7506 10.1128/JVI.00400-09 19474103
44. Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture. Brazeau E, et al. J Neurovirol 2011 17 3 274 280 10.1007/s13365-011-0025-6 21479719
45. Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development. Estep RD, et al. J Virol 2007 81 6 2957 2969 10.1128/JVI.01997-06 17215283 (Pubitemid 46447059)
46. Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection. Robinson BA, et al. J Virol 2012 86 4 2197 2211 10.1128/JVI.05047-11 22156526
47. Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Wong CW, et al. Genome Res 2004 14 3 398 405 10.1101/gr.2141004 14993206 (Pubitemid 38386606)
48. Simian varicella virus: molecular virology. Gray WL, Curr Top Microbiol Immunol 2010 342 291 308 10.1007/82-2010-27 20369316
49. Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1. McNabb DS, Courtney RJ, Virology 1992 190 1 221 232 10.1016/0042-6822(92)91208-C 1326803
50. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. Heine JW, et al. J Virol 1974 14 3 640 651 4369085
51. Molecular genetics of herpes simplex virus. VIII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle. Batterson W, Furlong D, Roizman B, J Virol 1983 45 1 397 407 6296445 (Pubitemid 13166314)
52. Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. Knipe DM, Ruyechan WT, Roizman B, J Virol 1979 29 2 698 704 219255 (Pubitemid 9098438)
53. A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells. Desai PJ, J Virol 2000 74 24 11608 11618 10.1128/JVI.74.24.11608-11618. 2000 11090159 (Pubitemid 32222309)
54. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. Hendricks RL, et al. J Gen Virol 1991 72 Pt 7 1601 1610 1649898
55. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. Mikloska Z, Cunningham AL, J Virol 2001 75 23 11821 11826 10.1128/JVI.75.23.11821-11826.2001 11689663 (Pubitemid 33063273)
56. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. Sainz B Jr, Halford WP, J Virol 2002 76 22 11541 11550 10.1128/JVI.76.22.11541-11550.2002 12388715 (Pubitemid 35231310)